ICAM1-Negative Intravascular Large B-Cell Lymphoma of the Pituitary Gland: A Case Report and Literature Review.
AACE Clin Case Rep
; 7(4): 249-255, 2021.
Article
em En
| MEDLINE
| ID: mdl-34307847
ACTH, adrenocorticotropic hormone; BAL, bronchoalveolar lavage fluid analysis; CRH, corticotropin-releasing hormone; FDG, 18F-fluorodeoxyglucose; FSH, follicle-stimulating hormone; GH, growth hormone; GHRP2, growth hormone-releasing peptide 2; ICAM1; ICAM1, intercellular adhesion molecule 1; IVLBCL, intravascular large B-cell lymphoma; LDH, lactate dehydrogenase; LH, luteinizing hormone; LHRH, luteinizing hormone-releasing hormone; MEAM, ranimustine, etoposide, cytarabine, and melphalan; MTX, methotrexate; R-CHOP, rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone; R-hyper-CVAD/MA, rituximab plus hyper-fractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with methotrexate and cytarabine; TBLB, transbronchial lung biopsy; TRH, thyrotropin-releasing hormone; TSH, thyrotropin; hypopituitarism; intravascular; large B-cell lymphoma; pituitary; sIL2R, soluble IL-2 receptor
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Prognostic_studies
Idioma:
En
Revista:
AACE Clin Case Rep
Ano de publicação:
2021
Tipo de documento:
Article
País de afiliação:
Japão
País de publicação:
Estados Unidos